Inhibition of arthritis by L-type calcium channel antagonists ni

Details Inhibition of arthritis by L-type calcium channel antagonists ni Inhibition of arthritis by L-type calcium channel antagonists ni

1994-01-26

1995-12-26

Criares, T. J.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514355, A61K 3144

Patent

active

054788480

ABSTRACT:
The present invention comprises new methods for treating rheumatoid arthritis. It has been found that the L-type calcium channel antagonists are effective in treating arthritis. Nimodipine, nisoldipine, and nifedipine, are examples of specific compounds useful in the present invention.

REFERENCES:
patent: Re33963 (1992-06-01), Hegasy
patent: 3932645 (1976-01-01), Meyer et al.
patent: 4154839 (1979-05-01), Wehinger et al.
patent: 4537898 (1985-08-01), Hoff et al.
patent: 4600778 (1986-07-01), Teller et al.
patent: 4783337 (1988-11-01), Wong et al.
patent: 4788205 (1988-11-01), Cooper et al.
patent: 4857312 (1989-08-01), Hegasy et al.
patent: 4892730 (1990-01-01), Hegasy
patent: 4892741 (1990-01-01), Ohm et al.
patent: 4981683 (1991-01-01), Hegasy et al.
patent: 4988717 (1991-01-01), Wehinger et al.
Gay and Gay, Rheumatol. Int. 9, 105-113 (1989).
Kouri et al., Scand. J. Immunol. 19, 359-364 (1984).
Burmester et al., Scand. J. Immunol. 17, 68-82 (1983).
Baumgarten and Villereal, J. Biol. Chem. 267, 1524-10530 (1992).
Bernini et al., J. Cardiovasc. Pharmacol. 18, 42-45 (1991).
Hijioka et al., Mol. Pharmacol., 4, 435-440 (1992).
Kong et al., Second Messenger Phosphoproteins 13, 117-130 (1991).
Olsen et al., Biochem. Biophys. Res. Commun. 162, 448-455 (1989).
Dayer and Demczuk, Cytokines and Other Mediators in Rheumatoid Arthritis, Springer Seminars in Immunopathology, pp. 1-27 (Springer-Verlag 1984).
Gay and Koopman, Current Opinion in Rheumatology 1, 8-14 (1989).
Brennan et al., The Lancet Jul. 29, 224-247 (1989).
Taurog et al., Meth. Enzymol. 162, 339-355 (1988).
Otterness and Bliven et al., Nonsteroidal Anti-Inflammatory Drugs, pp. 111-252 (1985).
Ward, Am. J. Med., pp. 3-9 (1984).
Triggle and Janis, Structure and Physiology if the Slow Inward Calcium Channel, pp. 51-70 (1987).
Godfraind et al., Pharmacol. Rev. 38, 321-416 (1986).
Janis and Triggle, Drug Dev. Res. 4, 257-274 (1984).
Schramm et al., Nature 303, 535-537 (1983).
Scriabine, Rational Drug Therapy 21, 1-17 (1987).
Chen et al., Science 239, 1024 (1988).
Scriabine, Structure and Physiology of the Slow Inward Calcium Channel, pp. 51-70 (1987).
Jeurissen et al., Arthritis and Rheumatism 34, 961-972 (1991).
Yocum et al., Annals of Internal Medicine 109, 863-869 (1988).
Rau et al., Arthritis and Rheumatism 34, 1236-1244 (1991).

Affiliated with

Also associated with

Rating

Inhibition of arthritis by L-type calcium channel antagonists ni does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Inhibition of arthritis by L-type calcium channel antagonists ni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of arthritis by L-type calcium channel antagonists ni will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1369509